VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q80603731  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000335.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q80603731‏
024 ‎‡a  0000-0001-8475-2530‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q80603731‏
100 0 ‎‡a  Nguyen-Hai Nam‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Nguyen-Hai Nam‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Combretastatin-chalcone hybrids: synthesis and cytotoxicity.‏
670 ‎‡a  Author's Design, synthesis, and evaluation of novel N'-substituted-1-(4-chlorobenzyl)-1H-indol-3-carbohydrazides as antitumor agents‏
670 ‎‡a  Author's (E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity‏
670 ‎‡a  Author's Learning from Multiple Classifier Systems: Perspectives for Improving Decision Making of QSAR Models in Medicinal Chemistry.‏
670 ‎‡a  Author's New Acetohydrazides Incorporating 2-Oxoindoline and 4-Oxoquinazoline: Synthesis and Evaluation of Cytotoxicity and Caspase Activation Activity‏
670 ‎‡a  Author's Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis‏
909 ‎‡a  (orcid) 0000000184752530‏ ‎‡9  1‏
919 ‎‡a  learningfrommultipleclassifiersystemsperspectivesforimprovingdecisionmakingofqsarmodelsinmedicinalchemistry‏ ‎‡A  Learning from Multiple Classifier Systems: Perspectives for Improving Decision Making of QSAR Models in Medicinal Chemistry.‏ ‎‡9  1‏
919 ‎‡a  combretastatinchalconehybridssynthesisandcytotoxicity‏ ‎‡A  Combretastatin-chalcone hybrids: synthesis and cytotoxicity.‏ ‎‡9  1‏
919 ‎‡a  designsynthesisandevaluationofnovelnsubstituted14chlorobenzyl1hindol3carbohydrazidesasantitumoragents‏ ‎‡A  Design, synthesis, and evaluation of novel N'-substituted-1-(4-chlorobenzyl)-1H-indol-3-carbohydrazides as antitumor agents‏ ‎‡9  1‏
919 ‎‡a  enarylidene24oxoquinazolin43hylacetohydrazidessynthesisandevaluationofantitumorcytotoxicityandcaspaseactivationactivity‏ ‎‡A  (E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity‏ ‎‡9  1‏
919 ‎‡a  novelhydroxamicacidsincorporating11h123triazol4ylmethyl3substituted2oxoindolinessynthesisbiologicalevaluationandsaranalysis‏ ‎‡A  Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis‏ ‎‡9  1‏
919 ‎‡a  newacetohydrazidesincorporating2oxoindolineand4oxoquinazolinesynthesisandevaluationofcytotoxicityandcaspaseactivationactivity‏ ‎‡A  New Acetohydrazides Incorporating 2-Oxoindoline and 4-Oxoquinazoline: Synthesis and Evaluation of Cytotoxicity and Caspase Activation Activity‏ ‎‡9  1‏
996 ‎‡2  DNB|170818500
996 ‎‡2  BNF|12293075
996 ‎‡2  DNB|125202083X
996 ‎‡2  ISNI|0000000433825199
996 ‎‡2  LC|nr 98014702
996 ‎‡2  DNB|114700871X
996 ‎‡2  LC|n 85047507
996 ‎‡2  ISNI|0000000063846848
996 ‎‡2  LC|n 86102135
996 ‎‡2  SUDOC|034472991
996 ‎‡2  DNB|1035783584
996 ‎‡2  LC|no2017002046
996 ‎‡2  LC|n 2014045131
996 ‎‡2  ISNI|0000000453370398
996 ‎‡2  DNB|1222530384
996 ‎‡2  NUKAT|nx2024023979
996 ‎‡2  BNF|12215076
996 ‎‡2  LC|n 2009003047
996 ‎‡2  BNF|16973283
996 ‎‡2  DNB|1158478763
996 ‎‡2  ISNI|0000000039083553
996 ‎‡2  LC|no2014008458
996 ‎‡2  LC|nr 98013542
996 ‎‡2  ISNI|0000000040922764
996 ‎‡2  LC|n 92039656
996 ‎‡2  ISNI|0000000450542975
996 ‎‡2  SZ|1263890857
996 ‎‡2  DNB|1338733176
996 ‎‡2  ISNI|0000000082046037
996 ‎‡2  LC|n 94072737
996 ‎‡2  ISNI|0000000001938720
996 ‎‡2  ISNI|0000000058554701
996 ‎‡2  LC|no2002029686
996 ‎‡2  BNF|14512257
996 ‎‡2  ISNI|0000000066454102
996 ‎‡2  NII|DA06741308
996 ‎‡2  BNF|15573914
996 ‎‡2  ISNI|0000000031533089
996 ‎‡2  SUDOC|118177222
996 ‎‡2  LC|no2016134964
996 ‎‡2  LC|no2007106786
996 ‎‡2  BNF|10573152
996 ‎‡2  BNF|17755999
996 ‎‡2  ISNI|0000000054724128
996 ‎‡2  DNB|1209487853
996 ‎‡2  DNB|1146265220
996 ‎‡2  LC|no2008051644
996 ‎‡2  BNF|14580612
996 ‎‡2  LC|n 78023784
996 ‎‡2  LC|no2010086498
996 ‎‡2  LC|n 2015246044
996 ‎‡2  ISNI|0000000054820769
996 ‎‡2  DNB|1243723920
996 ‎‡2  DNB|1263890857
996 ‎‡2  LC|nr2001035130
996 ‎‡2  ISNI|000000001230052X
996 ‎‡2  ISNI|0000000458606320
996 ‎‡2  ISNI|0000000033470579
996 ‎‡2  LC|n 98104885
996 ‎‡2  ISNI|0000000037052702
996 ‎‡2  LC|n 2005209427
996 ‎‡2  ISNI|0000000038504205
996 ‎‡2  DNB|1247767884
996 ‎‡2  DNB|1315335581
996 ‎‡2  DNB|109373642
996 ‎‡2  ISNI|0000000121404862
996 ‎‡2  LC|no2009035609
996 ‎‡2  DNB|1315285312
996 ‎‡2  ISNI|0000000384189391
996 ‎‡2  ISNI|0000000005704905
996 ‎‡2  BNE|XX5076626
996 ‎‡2  ISNI|0000000430438281
996 ‎‡2  LC|n 96052888
996 ‎‡2  ISNI|0000000098967455
996 ‎‡2  BNF|15638649
996 ‎‡2  LC|n 96011493
996 ‎‡2  ISNI|0000000047191757
996 ‎‡2  DNB|123984033
996 ‎‡2  BNF|13483964
996 ‎‡2  LC|n 89618738
996 ‎‡2  LC|no2009013680
996 ‎‡2  J9U|987007350792405171
996 ‎‡2  CAOONL|ncf11921129
996 ‎‡2  LC|n 82024497
996 ‎‡2  BNF|16986531
996 ‎‡2  ISNI|0000000000427566
996 ‎‡2  LC|n 2014022574
996 ‎‡2  ISNI|0000000052668118
996 ‎‡2  DNB|129431117
996 ‎‡2  LC|n 2010009376
996 ‎‡2  LC|no2015157511
996 ‎‡2  DNB|1036303012
996 ‎‡2  SUDOC|035542527
996 ‎‡2  ISNI|0000000370061362
996 ‎‡2  SUDOC|116472847
996 ‎‡2  ISNI|0000000383789440
996 ‎‡2  LC|n 95060451
996 ‎‡2  ISNI|0000000416092245
996 ‎‡2  DBC|87097968743192
996 ‎‡2  DNB|1159326509
996 ‎‡2  PLWABN|9810551690605606
996 ‎‡2  ISNI|0000000083108324
996 ‎‡2  ISNI|0000000051034586
996 ‎‡2  ISNI|0000000000142309
996 ‎‡2  DNB|1136884238
996 ‎‡2  BNF|12522573
996 ‎‡2  BNF|13018596
996 ‎‡2  CAOONL|ncf11891978
996 ‎‡2  BIBSYS|14025638
996 ‎‡2  DNB|1146603347
996 ‎‡2  BNF|17905540
996 ‎‡2  LC|n 2015037625
996 ‎‡2  CAOONL|ncf11654089
996 ‎‡2  DNB|121749924
996 ‎‡2  LC|n 2010048921
996 ‎‡2  ISNI|0000000033440986
996 ‎‡2  SUDOC|030810523
996 ‎‡2  NUKAT|n 2017001697
996 ‎‡2  DNB|1230343245
996 ‎‡2  LC|n 93000469
996 ‎‡2  LC|no2015167836
996 ‎‡2  LC|n 2012024587
996 ‎‡2  LC|no2003085630
996 ‎‡2  BNF|14518672
996 ‎‡2  LC|n 2006221201
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏